Streetbeat News

Analyst Ratings

APP

BMBL

BTAI

LQDT

MNDY

NVDA

OLLI

ROST

WDAY

Several analyst forecasts were released on Tuesday, with price target changes for multiple companies. Notably, B of A Securities lowered the price target for Valero Energy Corporation (BMBL) and downgraded the stock from Buy to Neutral. Wells Fargo boosted Ollie's Bargain Outlet Holdings, Inc. (OLLI) price target. UBS boosted NVIDIA Corporation (NVDA) price target, and the shares gained 7.1%. Barclays raised Ross Stores, Inc. (ROST) price target. Jefferies increased Workday, Inc. (WDAY) price target. Truist Securities increased the price target for AppLovin Corporation (APP) and BioXcel Therapeutics, Inc. (BTAI). Keybanc boosted monday.com Ltd. (MNDY) price target. Barrington Research increased Liquidity Services, Inc. (LQDT) price target.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 12:38 pm

DY

Wells Fargo analyst Eric Luebchow has maintained an Overweight rating on Dycom Industries (NYSE:DY) but lowered the price target from $120 to $115.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:38 pm

KORE

TD Cowen analyst Colby Synesael maintains an Outperform rating on Kore Group Holdings (NYSE:KORE) but lowers the price target from $4.75 to $4.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 12:37 pm

FRHC

Freedom Holding's shares are trading lower following a short report from Hindenburg Research.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:36 pm

TSBX

B of A Securities analyst Geoff Meacham has initiated coverage on Turnstone Biologics (NASDAQ:TSBX) with a Buy rating and a price target of $18.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 12:35 pm

DCTH

SCYX

SE

Delcath Systems, Inc. (DCTH) has received FDA approval for HEPZATO KIT™, causing its stock to surge by 138%. SCYNEXIS (SCYX) received a 'Buy' rating from Ladenburg Thalmann & Co., leading to a 37% increase in its stock. Sea Limited (SE) reported a GAAP EPS of $0.54, beating estimates by $0.08, but its revenue of $3.1B missed estimates by $150M, causing an 18% drop in its stock.

Portfolio Pulse from ryanfaloona@benzinga.com

August 15, 2023 | 12:35 pm

CYTK

SVB Leerink analyst Roanna Ruiz has initiated coverage on Cytokinetics (NASDAQ:CYTK) with an Outperform rating and a price target of $58.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 12:33 pm

ACLX

Stifel analyst Benjamin Burnett maintains a 'Buy' rating on Arcellx (NASDAQ:ACLX) but has lowered the price target from $54 to $52.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 12:33 pm

CPSI

Cantor Fitzgerald analyst Steven Halper has initiated coverage on CPSI (NASDAQ:CPSI) with an Overweight rating and a price target of $24.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 12:33 pm

HNHPF

NVDA

Nvidia Corp's stock is trading higher amid reports of Saudi Arabia and the UAE aggressively acquiring the chipmaker's high-end chips for AI software development. This has intensified the global demand for these chips. Saudi Arabia has procured at least 3,000 Nvidia H100 chips, each valued at $40,000, while the UAE has also procured Nvidia chips. Foxconn has secured a significant order to produce chip substrates for Nvidia's HGX AI servers, meeting over half of Nvidia's total demand. UBS analyst Timothy Arcuri maintained Nvidia with a Buy and raised the price target from $475 to $540.

Portfolio Pulse from Anusuya Lahiri

August 15, 2023 | 12:33 pm